TC Medical(SH:600763)2016-10-14 16:00Financial Performance - Operating income for the first nine months rose by 14.27% to CNY 639,681,412.44 compared to the same period last year[6] - Net profit attributable to shareholders increased by 1.08% to CNY 123,765,037.63 compared to the same period last year[6] - Total revenue for Q3 2016 reached ¥260,357,375.96, an increase of 20% compared to ¥216,957,222.99 in Q3 2015[28] - Net profit for the first nine months of 2016 was ¥154,129,560.00, a decrease from ¥159,972,190.00 in the same period of 2015[29] - The company's net profit attributable to shareholders was CNY 51,391,375.67 for Q3 2016, a decrease of 4.3% compared to CNY 54,549,962.31 in Q3 2015[31] - The total comprehensive income attributable to shareholders was CNY 55,031,523.78 in Q3 2016, down from CNY 57,409,198.12 in the same period last year, reflecting a decline of 4.1%[34] - The company's operating revenue for the first nine months of 2016 was CNY 86,820,390.03, an increase of 4.8% from CNY 83,422,950.87 in the same period last year[33] - The total profit for the first nine months of 2016 was CNY 7,603,485.60, compared to CNY 15,973,082.89 in the same period last year, representing a decrease of 52.5%[34] Assets and Liabilities - Total assets increased by 3.80% to CNY 1,380,461,784.59 compared to the end of the previous year[6] - Net assets attributable to shareholders increased by 15.06% to CNY 945,849,754.56 compared to the end of the previous year[6] - Accounts receivable increased by 76.82% to RMB 20,684,434.67 due to an increase in medical insurance receivables[13] - Other receivables surged by 539.77% to RMB 28,746,863.00 primarily due to increased deposits for hospital rent and property fees[13] - Inventory rose by 31.21% to RMB 26,718,590.00 as a result of increased procurement of medical materials[13] - Construction in progress increased by 58.77% to RMB 59,468,090.27 due to higher investments in subsidiary hospital construction[13] - Total liabilities decreased to RMB 353,143,421.64 from RMB 436,404,616.15 at the beginning of the year[21] - The company's equity attributable to shareholders increased to RMB 945,849,754.56 from RMB 822,084,716.75 at the beginning of the year[22] Cash Flow - Net cash flow from operating activities decreased by 47.48% to CNY 74,762,494.44 compared to the same period last year[6] - Operating cash flow decreased by 47.48% to RMB 74,762,494.44, mainly due to increased payments for employee compensation and taxes[14] - Cash inflow from operating activities for the year-to-date period reached ¥641,991,066.46, an increase of 11.93% compared to ¥573,553,171.99 in the previous year[36] - Total cash outflow from operating activities amounted to ¥567,228,572.02, which is an increase of 31.6% compared to ¥431,203,676.96 in the previous year[37] - The ending cash and cash equivalents balance was ¥284,493,659.50, compared to ¥266,272,339.88 at the end of the same period last year[38] - The company reported a net decrease in cash and cash equivalents of -¥15,570,127.61, contrasting with an increase of ¥11,101,030.48 in the previous year[38] Shareholder Information - The total number of shareholders reached 19,876[11] - The largest shareholder, Hangzhou Baoqun Industrial Group Co., Ltd., holds 33.75% of shares[11] - The company plans to continue share repurchases, with a commitment to buy back shares worth no less than RMB 15 million, but not exceeding 2% of the total issued shares[18] - The first employee stock ownership plan has been approved to enhance employee motivation and company competitiveness[16] Future Plans - The company plans to establish Hangzhou North Dental Hospital with a registered capital of RMB 10 million, where it will hold a 61% stake[15] - The company intends to set up Hangzhou Dental Hospital Shengxin Branch with a proposed registered capital of RMB 6 million, holding a 60% stake[15] - The company plans to expand its market presence and invest in new product development to drive future growth[29] Financial Ratios and Metrics - The weighted average return on net assets decreased by 3.72 percentage points to 14.00%[7] - Basic and diluted earnings per share increased by 2.63% to CNY 0.39[7] - The company reported a gross profit margin of approximately 26% for Q3 2016, compared to 27% in Q3 2015[28] - The company's financial expenses for the first nine months of 2016 were CNY -1,967,212.46, an improvement from CNY -2,689,104.84 in the previous year[33] - The company reported an asset impairment loss of CNY 1,967,762.29 for the first nine months of 2016, significantly higher than CNY 525,874.90 in the same period last year[33]